A variable proportion of individuals fails to achieve a CD4+ T cell number above 500/μL, despite chronic suppression of HIV-1 replication, and this suboptimal recovery increases the risk of many comorbidities (heart, renal, metabolic, bone diseases, and cancers) as well as all-cause mortality. Here, CD4 is linked to cancer.